Showing results (111-120 of 516) with videos related to
Sort By:
Pageof 52
Leukemia & Lymphoma|June 15, 2017
Overcoming multiple myeloma drug resistance in the era of cancer 'omics'Matthew Ho Zhi Guang, Amanda McCann, Giada Bianchi, et al.American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 21, 2024
Navigating High-Risk and Ultrahigh-Risk Multiple Myeloma: Challenges and Emerging StrategiesMatthew J Rees, Mattia D'Agostino, Lisa B Leypoldt, et al.Journal of Leukocyte Biology|June 12, 2012
Pivotal Advance: Protein synthesis modulates responsiveness of differentiating and malignant plasma cells to proteasome inhibitorsSimone Cenci, Laura Oliva, Fulvia Cerruti, et al.Leukemia & Lymphoma|January 19, 2008
Troponin T level as an exclusion criterion for stem cell transplantation in light-chain amyloidosisMorie Gertz, Martha Lacy, Angela Dispenzieri, et al.Blood Cancer Journal|February 16, 2023
Artificial intelligence-enabled screening strategy for drug repurposing in monoclonal gammopathy of undetermined significanceAlexander J Ryu, Shaji Kumar, Angela Dispenzieri, et al.British Journal of Haematology|February 22, 2020
Mass cytometry identifies expansion of double positive and exhausted T cell subsets in the tumour microenvironment of patients with POEMS syndromeTaxiarchis V Kourelis, Dragan Jevremovic, Erik Jessen, et al.Blood Cancer Journal|August 30, 2019
Mass cytometry dissects T cell heterogeneity in the immune tumor microenvironment of common dysproteinemias at diagnosis and after first line therapiesTaxiarchis V Kourelis, Jose C Villasboas, Erik Jessen, et al.Research Square|February 27, 2026
Metabolic Heterogeneity and Niche Rewiring in Plasma Cells are Associated with Progression from MGUS to Multiple MyelomaAxel Walch, Guoxing Zhang, Na Sun, et al.Blood|July 31, 2009
Inhibition of histone deacetylase overcomes rapamycin-mediated resistance in diffuse large B-cell lymphoma by inhibiting Akt signaling through mTORC2Mamta Gupta, Stephen M Ansell, Anne J Novak, et al.Clinical Lymphoma, Myeloma & Leukemia|April 26, 2025
Treatment Patterns and Clinical Outcomes of Patients With Systemic Light Chain Amyloidosis in the United States: Evidence From Real-World Clinical PracticeSophia S Li, Anita D'Souza, Suzanne Lentzsch, et al.Pageof 52